Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B.
Sherman M, Yurdaydin C, Sollano J, Silva M, Liaw YF, Cianciara J, Boron-Kaczmarska A, Martin P, Goodman Z, Colonno R, Cross A, Denisky G, Kreter B, Hindes R; AI463026 BEHoLD Study Group.
Sherman M, et al. Among authors: kreter b.
Gastroenterology. 2006 Jun;130(7):2039-49. doi: 10.1053/j.gastro.2006.04.007.
Gastroenterology. 2006.
PMID: 16762627
Clinical Trial.